EAF1 Polyclonal Antibody

Dodavatel: Reddot Biotech USA Inc.
Teplota skladování: Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Katalogové číslo: RD88954A/120
Velikost balení: 120μL
Cena bez DPH: 12 365,00 Kč
Dostupnost: NA OBJEDNÁNÍ
Vložit do košíku
Zobrazovat ceny: bez DPH / včetně DPH
This is a EAF1 Polyclonal Antibody from Reddot Biotech. This product is for Research Use Only.
Actin is a key regulator of RNA polymerase (Pol) II-dependent transcription. Positive transcription elongation factor b (P-TEFb), a Cdk9/cyclin T1 heterodimer, has been reported to play a critical role in transcription elongation. However, the relationship between actin and P-TEFb is still not clear. In this study, actin was found to interact with Cdk9, a catalytic subunit of P-TEFb, in elongation complexes. Using immunofluorescence and immunoprecipitation assays, Cdk9 was found to bind to G-actin through the conserved Thr-186 in the T-loop. Overexpression and in vitro kinase assays showed that G-actin promotes P-TEFb-dependent phosphorylation of the Pol II C-terminal domain. An in vitro transcription experiment revealed that the interaction between G-actin and Cdk9 stimulated Pol II transcription elongation. ChIP and immobilized template assays indicated that actin recruited Cdk9 to a transcriptional template in vivo and in vitro. Using cytokine IL-6-inducible p21 gene expression system, we revealed that actin recruited Cdk9 to endogenous gene. Moreover, overexpression of actin and Cdk9 increased histone H3 acetylation and acetylized histone H3 binding to a transcriptional template through the interaction with histone acetyltransferase, p300. Taken together, our results suggested that actin participates in transcription elongation by recruiting Cdk9 for phosphorylation of the Pol II C-terminal domain, and the actin-Cdk9 interaction promotes chromatin remodeling.
ClonalityPolyclonal
Purification MethodAffinity purification
IsotypeIgG
HostRabbit
ImmunogenRecombinant fusion protein of human EAF1
Gene ID85403
SwissprotQ96JC9
Observed MW58kDa
ReactivityHuman,Rat
ApplicationsWB
ConjugationUnconjugated
DilutionWB 1:500-1:2000
Concentration1mg/mL
BufferPBS with 0.01% thiomersal,50% glycerol,pH7.3.
0
RD88954A/120